CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale Chief Medical Officer sold 3,208 shares at $15.43 ($49,499)
- 4 Open-market sale Chief R & QA Officer sold 4,153 shares at $15.35 ($63,749)
- 4 Exercise or conversion Chief Executive Officer acquired 5,908 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 6,000 shares at $15.49 ($92,940)
- 4 Grant or award Chief Medical Officer acquired 55,900 shares (grant or award)
- 4 Grant or award Chief R & QA Officer acquired 42,857 shares (grant or award)
- 4 Grant or award VP, General Counsel & Sec. acquired 48,857 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 27 of 33 · 645 filings